We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CYH:NYSECommunity Health Systems, Inc. Analysis

Data as of 2026-06-17 - not real-time

$3.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Community Health Systems (CYH) trades around $3, well below its 20‑day SMA (≈$2.87) and 200‑day SMA (≈$3.17), yet the price remains above the identified support of $2.68, suggesting limited downside cushion. The stock’s PE ratio of 0.87 is dramatically lower than the industry average of 24.3, indicating apparent undervaluation, but this is offset by a negative book value per share and a debt load exceeding $10 bn, which raises balance‑sheet concerns. Technical indicators are mixed: MACD shows a bullish crossover while the overall trend is labeled bearish and volume is decreasing, implying weak buying pressure. Recent news highlights a strategic divestiture of four Arkansas hospitals, signaling a focus on portfolio optimization, but also notes a decline in Adjusted EBITDA, underscoring ongoing earnings pressure. The market sentiment is extremely greedy (Fear & Greed Index 88.5), yet volatility is high at 34% over the past 30 days and beta is above 1.5, reflecting heightened price swings. In this context, CYH appears undervalued from a pure price‑multiple perspective but carries substantial financial and execution risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price hovering near support with limited upside to resistance
  • Decreasing volume indicating weak short‑term demand
  • Mixed technical signals (bullish MACD vs bearish trend)

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Substantially low PE relative to peers suggesting valuation upside
  • Strategic asset divestitures aimed at improving cash flow
  • Potential upside of ~10% based on upside/downside projection

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued price metrics if balance‑sheet restructuring succeeds
  • Industry demand for acute‑care services providing a stable revenue base
  • Long‑term upside potential outweighing current financial strain

Key Metrics & Analysis

Financial Health

Revenue Growth-6.10%
Profit Margin3.78%
P/E Ratio0.9
ROA4.68%
P/B Ratio-0.3
Op. Cash Flow$126.0M
Free Cash Flow$337.9M
Industry P/E24.3

Technical Analysis

TrendBearish
RSI55.5
Support$2.68
Resistance$3.18
MA 20$2.87
MA 50$2.90
MA 200$3.17
MACDBullish
VolumeDecreasing
Fear & Greed Index88.5

Valuation

Target Price$3.31
Upside/Downside10.48%
GradeUndervalued
TypeValue

Risk Assessment

Beta1.30
Volatility34.25%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.